Coronavirus has nearly halted in-office women's health appointments and care. From IVF clinic closures to maternity visits transpiring via telemedicine, healthy women are being put at risk because of the pandemic. Boulder's robust femtech community has solutions for women to control their own care. Join leaders of Prima-Temp, Mama Mend, MfB Fertility and Babyscripts for an important discussion on the future of women's health during a pandemic.
FemTech Now, COVID spotlight
Kristin is a healthcare leader, passionate brand strategist, and innovative catalyst. For over twenty years, she has worked client-side and as an advisor to the world’s largest consumer healthcare, pharmaceutical, and CPG companies. She is passionate about changing the way healthcare is delivered and experienced today.
Most recently, Kristin built and led the healthcare vertical at a global brand and innovation consultancy. She focused on uncovering insights, guiding strategy, and fueling innovation for the world’s largest brands - including a variety of life science, digital health, and consumer healthcare companies.
Her love for health and wellness started when she spent nearly six years at Eli Lilly launching five blockbuster drugs while rotating through different roles in the sales and marketing divisions.
Kristin's education is anchored in a foundation of marketing and organizational behavior - receiving her MBA from the University of Colorado and undergraduate degree from the Indiana University Kelley School of Business.
Sara is the CEO and co-founder at MamaMend (Techstars ‘18), a digital marketplace that informs and connects new mothers to perinatal health specialists. A data scientist by trade, Sara has advised numerous startups on data science and machine learning strategy and is a co-founder and organizer of the Boulder Women in Machine Learning & Data Science (WiMLDS).
I had trouble conceiving for over three years and pursued in-vitro fertilization treatment to conceive my son. To try to avoid the emotional challenge of another round of IVF, I took my PhD in Pharmacology and expertise in hormone signaling and began tracking my hormone levels at home. In doing so, I discovered I had a problem with ovulation —which was causing me to lose pregnancy after pregnancy. With hormone supplements, I was able to conceive without the help of IVF, and maintain a healthy pregnancy. After my daughter was born, my mission was clear—to empower women with vital knowledge that could help in their ability to conceive. I founded MFB Fertility, Inc. and invented the Proov test in my own basement, which now allows women to confirm successful ovulation by tracking PdG in just five minutes, at home.
Judith founded iBirth in 2009 as one of the first “femtech” solutions long before that term became established in the tech marketplace. After the iBirth acquisition by Babyscripts in 2018, Judith worked to merge the visions of the two companies to enhance and extend the reach of both solutions. In her time at iBirth and Babyscripts, Judith contributed to the deployment of digital point-of-care solutions to over one million families in the U.S. and globally through the B2B and B2C sectors, delivering configurable solutions to providers and payers who prescribe the technology to patients and members.
Amy Wedeking Shannon, the Chief Commercial Officer at Prima-Temp, has led commercial activities, representing the spectrum of healthcare from population to personalized medicine. Amy held roles of increasing responsibility in sales, business development, and finance with Eli Lilly and Guidant Corporation. As the leader of Sales and Marketing at Medical Simulation Corporation, Amy and her team identified and created a new hospital market, never serviced by the simulation industry, focused on areas of high economic and mortality impact. Amy represented Welltok, a machine learning data-driven, enterprise SaaS company and led sales and marketing for Flagship Biosciences, an AI driven, computational tissue analysis platform to support drug development. As a consultation partner and founder of CaliberOne Solutions, she advanced the commercial objectives of her clients. Amy has served as an Industry Advisor to the Leapfrog Group on Patient Safety, a Facilitator of the Medical Ethics course at the University of Colorado Medical School and volunteer with the Colorado Bioscience Association. Amy earned her Bachelors Degree in Molecular and Cellular Developmental Biology at the University of Colorado and her Masters of Business Administration at Duke University.